• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌衍生生长因子作为人肝门部胆管癌预后因素的表达及临床意义。

Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.

机构信息

Department of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan, People's Republic of China.

出版信息

Ann Surg Oncol. 2011 Mar;18(3):872-9. doi: 10.1245/s10434-010-1303-x. Epub 2010 Sep 17.

DOI:10.1245/s10434-010-1303-x
PMID:20848225
Abstract

BACKGROUND

Overexpressions of hepatoma-derived growth factor (HDGF) and vascular endothelial growth factor (VEGF) play important roles in the development and progression of cancers. This study investigates the expression of HDGF combined with VEGF, their correlation with clinicopathologic features, and their prognosis in human hilar cholangiocarcinoma.

MATERIALS AND METHODS

The expressions of HDGF and VEGF were analyzed by immunohistochemistry using the streptavidin peroxidase complex method for 58 patients with hilar cholangiocarcinoma receiving surgery. Their correlation with clinicopathologic features was then investigated. The relationships between them and the survival time of patients were retrospectively analyzed.

RESULTS

HDGF and VEGF were positively expressed in 27 (46.6%) and 42 (72.4%) patients, respectively. HDGF and VEGF had a positive correlation (r = 0.370, P = 0.004) in the Spearman rank correlation analysis. HDGF expression was associated with gender and histological type. Patients with positive HDGF expression had a significantly poorer overall survival rate than those with negative HDGF expression (35.7 vs. 73.3%, P = 0.003). Multivariate analysis showed that HDGF expression is an independent prognostic factor.

CONCLUSIONS

HDGF expression significantly correlates with VEGF expression and is a valuable prognostic factor for human hilar cholangiocarcinoma.

摘要

背景

肝癌衍生生长因子(HDGF)和血管内皮生长因子(VEGF)的过表达在癌症的发展和进展中起着重要作用。本研究探讨了 HDGF 与 VEGF 的表达,及其与人类肝门部胆管癌临床病理特征的相关性,并分析其对预后的影响。

材料与方法

采用免疫组织化学链霉亲和素过氧化物酶复合物法检测 58 例接受手术治疗的肝门部胆管癌患者的 HDGF 和 VEGF 表达,分析其与临床病理特征的关系,并对其与患者生存时间的关系进行回顾性分析。

结果

HDGF 和 VEGF 的阳性表达率分别为 46.6%(27/58)和 72.4%(42/58)。Spearman 秩相关分析显示,HDGF 和 VEGF 表达呈正相关(r=0.370,P=0.004)。HDGF 表达与性别和组织学类型有关。HDGF 阳性表达患者的总生存率明显低于 HDGF 阴性表达患者(35.7%比 73.3%,P=0.003)。多因素分析显示,HDGF 表达是独立的预后因素。

结论

HDGF 表达与 VEGF 表达显著相关,是人类肝门部胆管癌有价值的预后因素。

相似文献

1
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.肝癌衍生生长因子作为人肝门部胆管癌预后因素的表达及临床意义。
Ann Surg Oncol. 2011 Mar;18(3):872-9. doi: 10.1245/s10434-010-1303-x. Epub 2010 Sep 17.
2
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.CD24表达是肝内胆管癌的一个预后因素。
Cancer Lett. 2006 Apr 8;235(1):34-9. doi: 10.1016/j.canlet.2005.03.059. Epub 2005 Aug 25.
3
A case of mucin-producing cholangiocarcinoma.一例黏液生成性胆管癌。
Jpn J Clin Oncol. 2009 Jul;39(7):467. doi: 10.1093/jjco/hyp071.
4
[Correlation between PPARgamma and VEGF-C expression in extrahepatic cholangioadenocarcinoma (EHCAC) and their prognostic significance].[肝外胆管腺癌(EHCAC)中PPARγ与VEGF-C表达的相关性及其预后意义]
Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):773-7.
5
Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.肝星状细胞可能与肝内胆管癌的进展有关。
Ann Surg Oncol. 2009 Sep;16(9):2555-64. doi: 10.1245/s10434-009-0568-4. Epub 2009 Jun 23.
6
Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.在肝内胆管癌中,侵袭前沿的腱生蛋白表达与预后不良相关。
Mod Pathol. 2003 Oct;16(10):1019-27. doi: 10.1097/01.MP.0000086860.65672.73.
7
Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.水通道蛋白-1在肝内胆管癌中的下调与肿瘤进展及黏蛋白表达有关。
Hum Pathol. 2007 Dec;38(12):1819-25. doi: 10.1016/j.humpath.2007.04.016. Epub 2007 Sep 14.
8
Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).金属硫蛋白过表达及其在肝内胆管癌和肝外肝门胆管癌(克氏瘤)中的预后相关性。
Hum Pathol. 2009 Dec;40(12):1706-14. doi: 10.1016/j.humpath.2009.01.026. Epub 2009 Aug 14.
9
Biliary intraductal papillary mucinous neoplasia: three case reports.胆管内乳头状黏液性肿瘤:三例报告
Virchows Arch. 2009 May;454(5):589-94. doi: 10.1007/s00428-009-0767-1. Epub 2009 Apr 4.
10
Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.肝癌衍生生长因子:肝内胆管癌的一种新型预后生物标志物。
Tumour Biol. 2015 Jan;36(1):353-64. doi: 10.1007/s13277-014-2651-0. Epub 2014 Sep 28.

引用本文的文献

1
Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma.肝门部胆管癌术前预后生物标志物的系统评价
Cancers (Basel). 2024 Feb 7;16(4):698. doi: 10.3390/cancers16040698.
2
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma.基于组学的平台:在胆管癌中的现状和潜在应用。
Biomolecules. 2020 Sep 28;10(10):1377. doi: 10.3390/biom10101377.
3
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies.肝癌衍生生长因子:概述及其作为消化系恶性肿瘤潜在治疗靶标分子的作用。
Int J Mol Sci. 2020 Jun 13;21(12):4216. doi: 10.3390/ijms21124216.
4
Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.肝癌衍生生长因子和DDX5通过激活β-连环蛋白促进子宫内膜癌的发生和进展。
Front Oncol. 2019 Apr 11;9:211. doi: 10.3389/fonc.2019.00211. eCollection 2019.
5
The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.肝癌衍生生长因子在确定乳腺癌预后、评估肿瘤细胞侵袭概率、复发及淋巴结转移方面的评估
J Family Med Prim Care. 2017 Oct-Dec;6(4):770-774. doi: 10.4103/jfmpc.jfmpc_177_17.
6
Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.下调肝癌衍生生长因子的表达通过抑制上皮间质转化和 MMP2、MMP9 抑制前列腺癌细胞的迁移和侵袭。
PLoS One. 2018 Jan 4;13(1):e0190725. doi: 10.1371/journal.pone.0190725. eCollection 2018.
7
The expression and clinical significance of HDGF in osteosarcoma.HDGF 在骨肉瘤中的表达及临床意义。
Onco Targets Ther. 2015 Sep 9;8:2509-17. doi: 10.2147/OTT.S91708. eCollection 2015.
8
Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.肝癌衍生生长因子预示上皮性卵巢癌预后不良。
Onco Targets Ther. 2015 Aug 13;8:2101-9. doi: 10.2147/OTT.S85660. eCollection 2015.
9
Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.肝癌衍生生长因子:肝内胆管癌的一种新型预后生物标志物。
Tumour Biol. 2015 Jan;36(1):353-64. doi: 10.1007/s13277-014-2651-0. Epub 2014 Sep 28.
10
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.核 HDGF 的上调预示着阴茎鳞癌患者的预后不良,可绕过 VEGF-A 和 Ki-67。
Med Oncol. 2013 Dec;30(4):702. doi: 10.1007/s12032-013-0702-9. Epub 2013 Sep 3.